Curative Biotechnology Statistics
Total Valuation
CUBT has a market cap or net worth of 7.51 million. The enterprise value is 10.96 million.
| Market Cap | 7.51M |
| Enterprise Value | 10.96M |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CUBT has 1.07 billion shares outstanding. The number of shares has increased by 78.09% in one year.
| Current Share Class | 1.07B |
| Shares Outstanding | 1.07B |
| Shares Change (YoY) | +78.09% |
| Shares Change (QoQ) | +7.11% |
| Owned by Insiders (%) | 17.86% |
| Owned by Institutions (%) | n/a |
| Float | 859.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.86 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 34.65% |
| Weighted Average Cost of Capital (WACC) | 14.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -709,552 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.38% in the last 52 weeks. The beta is 1.35, so CUBT's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -45.38% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 53.42 |
| Average Volume (20 Days) | 527,373 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.04M |
| Pretax Income | -2.75M |
| Net Income | -2.84M |
| EBITDA | -1.95M |
| EBIT | -2.04M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 30,740 in cash and 3.48 million in debt, with a net cash position of -3.44 million or -0.00 per share.
| Cash & Cash Equivalents | 30,740 |
| Total Debt | 3.48M |
| Net Cash | -3.44M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -5.88M |
| Book Value Per Share | -0.01 |
| Working Capital | -7.90M |
Cash Flow
| Operating Cash Flow | -637,193 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CUBT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -78.09% |
| Shareholder Yield | -78.09% |
| Earnings Yield | -37.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 23, 2010. It was a reverse split with a ratio of 0.02.
| Last Split Date | Aug 23, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |